Asceniv
Administration: IVIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 12+
Improving PI diagnosis with machine learning
April 25, 2023
Read article
Immunoglobulin inaccessible to some disabled by PI
April 25, 2023
Read article
Members of the IDF Giving Circle
make a difference in the lives of people living with PI and help the foundation reach the undiagnosed.
Project ECHO clinician series: Antibody deficiencies
April 24, 2023
Watch video
Give the gift of generosity
IDF relies on the generosity of donors and sponsors in order to provide services to patients, physicians, and researchers free of charge. Be a hero—contribute today and help better the lives of people living with PI.
Monitoring chimerism after transplant is critical to good health
April 21, 2023
Read article
Spring 2023 IDF ADVOCATE newsletter
April 21, 2023
View PDF
Second bivalent dose allowed for those at high risk from COVID-19
April 20, 2023
Read article
Study looks at long-term response to COVID vaccine in immunocompromised
April 20, 2023
Read article
